A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants

Clinical trial NCT06877624 · COMPLETED

Trial details

NCT number: NCT06877624
Sponsor: QurAlis Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2025-01-10
Primary completion: 2025-05-15
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.